Evidence map›Paper›PMID 18560820›Full record

Trial reportUrological research2008

Citraturic, alkalinizing and antioxidative effects of limeade-based regimen in nephrolithiasis patients.

Piyaratana Tosukhowong, Chatchai Yachantha, Thosaphol Sasivongsbhakdi, Supoj Ratchanon, Suchada Chaisawasdi, Chanchai Boonla, Kriang Tungsanga

Abstract readComparative StudyRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Urological research, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Lime juice as a dietary alternative to mist potassium citrate for urine alkalinisation: A prospective, cross-over clinical trial.Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia · 2023
    Article
  8. Cold-pressed oil fromExperimental and therapeutic medicine · 2022
    Article
  9. Review
  10. Article
  11. Epidemiology of stone disease across the world.World journal of urology · 2017
    Review
  12. Article
  13. Article
  14. Review
  15. An ethnobotanical survey of medicinal plants in Trinidad.Journal of ethnobiology and ethnomedicine · 2015
    Article
  16. Article
  17. Article
  18. Urolithiasis presenting as right flank pain: a case report.The Journal of the Canadian Chiropractic Association · 2013
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Piyaratana TosukhowongDepartment of Biochemistry, Faculty of Medicine, Chulalongkorn University, Bangkok, 10330, Thailand. fmedpts@md2.md.chula.ac.th
Chatchai Yachantha
Thosaphol Sasivongsbhakdi
Supoj Ratchanon
Suchada Chaisawasdi
Chanchai Boonla
Kriang Tungsanga
Chulalongkorn University · THKing Mongkut's University of Technology Thonburi · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Potassium citrate has long been used as a prophylactic remedy for nephrolithiasis recurrence. Lemonade consumption is also suggested as an option. We compared the efficacy of consumption of solution containing manufactured lime powder with that of potassium citrate, on the improvement of metabolic risk factors, oxidative stress and renal tubular damage in nephrolithiasis patients. Patients with kidney stone were enrolled and randomly assigned to three treatment programs for 3 month period consisting of consumption of solution containing lime powder (Group 1, n=13), potassium citrate (Group 2, n=11) and lactose as placebo regimen (Group 3, n=7). Lime powder and potassium citrate contained equal amounts of potassium (21 mEq) and citrate (63 mEq). After treatment, there was an increase in urinary pH, potassium and citrate in Group 1 and 2. Increased plasma potassium and red blood cell glutathione (R-GSH) and decreased urinary malondialdehyde were found in Group 1, but not observed in Group 2. R-GSH was decreased in Group 2. Urinary N-acetyl-beta-glucosaminidase activity and fractional excretion of magnesium, as renal tubular damage indicators, were decreased only in Group 1. In Group 3, all measured parameters were unaltered except for an increased urinary chloride. In conclusion, consumption of our in-house lime powder exerted citraturic and alkalinizing actions as efficient as consumption of potassium citrate. In addition, it provided an antioxidative effect and was able to attenuate renal tubular damage. These pharmacological properties may be clinically useful to diminish the stone-forming potential in kidney stone patients and hence for preventing recurrent calculi.

Indexed as

Citrus aurantiifoliaAdultAlkaliesAntioxidantsDiureticsFemaleHumansHydrogen-Ion ConcentrationKidney Function TestsMaleMiddle AgedNephrolithiasisOxidative StressPlant PreparationsPotassium CitrateProspective StudiesAlkaliesAntioxidantsDiureticsPlant PreparationsPotassium Citrate

Identifiers

PMID18560820
OpenAlexW2061261865

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.